Has Scott Sharp, MD received payments from drug or device companies?

Yes. Drug and device makers reported $41,219 in general payments to Scott Sharp, MD across 367 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Sharp, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Sharp, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Sharp, MD

Interventional Cardiology · Indianapolis, INNPI 1518966712

Payments from drug & device makers

$41,219in general payments, 2019–2025

Across 367 payments — averaging $112.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$32K
Boston Scientific$3K
Abiomed$637
Abbott$494
Cardiovascular Systems Inc.$349
AstraZeneca$333
plus $4K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	21	$32,274
Boston Scientific	66	$2,766
Abiomed	6	$637
Abbott	10	$494
Cardiovascular Systems Inc.	12	$349
AstraZeneca	13	$333
Novartis	17	$332
Johnson & Johnson	24	$330
Pfizer	19	$277
Merck	17	$259
Philips North America LLC	11	$232
Boehringer Ingelheim	11	$204
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	15	$202
Sanofi-aventis U.S. LLC	13	$197
Novo Nordisk	9	$195
Bayer	10	$183
Regeneron Healthcare Solutions, Inc.	9	$169
Amgen	11	$155
Amarin Pharma, Inc.	11	$136
Heartflow, Inc.	2	$115
Kiniksa Pharmaceuticals International, PLC	7	$109
Livanova USA, Inc.	2	$105
Vifor Pharma, Inc.	7	$100
Altathera Pharmaceuticals LLC	2	$92
Arrow International, Inc.	1	$77
Penumbra, Inc.	3	$76
Terumo Medical Corporation	3	$75
Stryker	2	$74
Mindray DS USA, Inc.	1	$66
EKOS Corporation	1	$53
Edwards Lifesciences	2	$53
Scpharmaceuticals Inc.	3	$51
E.r. Squibb & Sons, L.L.C.	3	$51
Lantheus Medical Imaging, Inc.	3	$50
Alnylam Pharmaceuticals Inc.	2	$42
Angiodynamics, Inc.	2	$39
Kowa Pharmaceuticals America, Inc.	3	$35
Biotronik Inc.	2	$31
Daiichi Sankyo Inc.	1	$28
Chiesi USA, Inc.	2	$27
Lexicon Pharmaceuticals, Inc.	2	$26
Integra Lifesciences Corporation	1	$24
Atricure, Inc.	1	$23
Bridgebio Pharma, Inc.	1	$20
Kiniksa Pharmaceuticals, Ltd.	1	$20
Medtronic	1	$17
Kestra Medical Technology Services, Inc.	1	$15

How this compares

$41,219 in reported general payments places this provider in the 80th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana →

Medicare billing

Part B allowed, 2024

$176,425

Medicare patients

576

Services billed

1,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Indianapolis

James HermillerIndianapolis$2.8M
Jeffrey BreallIndianapolis$955K
Brian BigelowIndianapolis$444K
Saeed ShaikhIndianapolis$366K
Woodrow CoreyIndianapolis$262K
Sandeep DubeIndianapolis$203K
Michael BallIndianapolis$138K
Mohammad ThawabiIndianapolis$136K
Anjan SinhaIndianapolis$82K
George RevtyakIndianapolis$50K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →